Contact
Home • Join Putnam • Why join Putnam?

Why join Putnam?

Empowerment. Collaboration. Meaning.

Check out our open roles

A message from our CEO.

What you can expect at Putnam.

An empowering team that challenges you to be your best.

See what’s possible when you’re at your best.

A collaborative culture that engages and excites curious minds.

Come for the work, stay for the culture.

Meaningful work that shapes the future of human health.

Be the reason that healthcare changes for the better.

More on our culture and philosophy

People spotlight.

Catriona Crossan

Principal, Head of Health Economic Modelling, HEOR

Read bio

Karan Raje

Principal

Read bio

About Karan and Catriona.

Karan and Catriona are both Principals with Putnam. Karan focuses on commercial strategy for both US and European clients, while Catriona is part of the Putnam PHMR team leading on health economic modeling team. Coming from unique backgrounds and skillsets, both Karan and Catriona enjoy being part of the firm’s culture and opportunities.

Our values.

Collaboration
Team. Trust. Compassion.

Excellence
Set high standards. Develop & retain our people. Exceptional experience.

Ingenuity
Creative thinking. Resourcefulness. Pushing boundaries.

Grit
Passion. Perseverance. Effort drives success.

Diversity
Inclusion. Respect. Better for it.

Do you share our values? Apply to an open role today
1988
Founded

Founded as a strategy consulting firm for the life sciences industry

2013
Milestone

“Reborn” as a new wave of management implements a new vision of growth

2015

San Francisco office opens and consultant headcount breaks 80

2017

New partners join the management team; named #1 boutique consulting firm by Vault

2019
Milestone

Joined Ashfield Advisory Group and positioned for continued growth

2020
New offices

NYC and London offices open; growing offerings for Value, Pricing & Access and Data Analytics

2021
Milestone

PHMR joins and grows Putnam’s Value, Pricing & Access practice area

2022
Milestone

Huntsworth and Ashfield unite as Inizio; Putnam welcomes SmartAnalyst and Creativ-Ceutical

Next
Next

Latest thinking.

Get the latest insights and perspectives from our experts.

Lessons to optimize EMA regulatory success using single-arm trials in oncology

We set out to understand the likelihood of regulatory approval of oncology-based single-arm trials by the European Medical Agency (EMA).

Read more

Medicare Price Negotiation: Putnam’s Round One Picks

As provisions of the Inflation Reduction Act (IRA) of 2022 begin to take effect, Putnam continues to analyze the implications…

Read more

New Principal out of London Joins Putnam

Putnam is pleased to announce the addition of Stephen McGarry to the team. Steve started with Putnam in June 2023 as a...

Read more

Distributional cost‑effectiveness analysis of treatments for non‑small cell lung cancer

Putnam aimed to conduct an aggregate DCEA of two NSCLC treatments recommended by NICE, and identify key drivers of the analysis.

Read more